MS is down 3.3% today at $184.36 (2:37 p.m. ET, Nov. 16), as the Nasdaq-100 falls too (QQQ down 2.5%). Over five trading days it is down 1.5%, and 14.8% below its three-month high.
Updated every 30 minutes while the market is open. Not investment advice.
MS is up 5.1% over five trading days, closing at $190.65 on Nov. 13, 2026. When a stock drops like this, the first question is whether the problem is the company or the whole group it trades with.
To answer that, we compare MS with its closest peers. We check the calendar for earnings and Fed dates. We also review Morgan Stanley's latest SEC filings and insider trades.
The chart below tracks MS's daily closing price from May 20, 2026 to Nov. 13, 2026. Over that stretch it is down 2.5%, from $195.48 to $190.65. The high was $225.90 on July 15, 2026. The low was $177.36 on Oct. 19, 2026. Red circles mark weeks when company insiders sold shares on the open market. There were 3 such weeks in this period. Bigger circles mean more money. No green diamonds appear. No insider bought on the open market in this window.
MS share price and insider trades
Daily closing price, May 20, 2026 to Nov 13, 2026 · dots are open-market trades by company insiders (SEC Form 4), one per week
Latest
$190.65
Nov 13, 2026
Change
▼ -2.5%
since May 20, 2026
High
$225.90
Jul 15, 2026
Low
$177.36
Oct 19, 2026
Share price Insider sales: $9.3M in 4 trades Insider buys: noneBigger dot = more money. Hover a dot or the line for details.
What could be behind the MS move
We found no Morgan Stanley earnings report in the last 10 days or the next three weeks. We also found no notable SEC filing in recent weeks. Nothing company-specific on the public record explains the move on its own.
The broader market is an uptrend under stress. The VIX volatility index stands at 19.3. The Federal Reserve's next rate decision is on Dec. 9, 2026, 23 days away. Market pricing puts the odds at 4% for a hold, 96% for a hike and 1% for a cut.
Also worth knowing about MS
Insiders sold $454,000 over 90 days and bought none on the open market. Sales are often routine, for taxes or pre-planned plans.
Dilution risk: moderate (35/100). Share count is down 1.7% over a year.
These are the specific events and levels to watch. None of them is a prediction.
The Jan. 14, 2027 earnings report is 59 days away. Morgan Stanley beat estimates in all 4 of the last 4 quarters, with an average surprise of +8.2%. A miss would break that pattern.
An open-market purchase by an insider at Morgan Stanley would show up in Form 4 filings within two business days of the trade. There has been none in 90 days.
Analyst ratings: the average score moved from 3.81 to 3.79 over three months. The scale runs from 5 for strong buy to 1 for strong sell. A run of downgrades after earnings usually shows up here first.
Price levels: a close above $225.9 would be a new 52-week high, 18.5% above the latest close of $190.65. A close below $151.78 would be a new 52-week low, 20.4% below it.
Growth: revenue rose 16.2% year over year in the quarter ending Sep 2026. The trend is steady. At a P/E of 15.1, a slowdown would matter more than at a lower multiple.
New shares: dilution risk is moderate now. A new shelf registration (S-3) or prospectus supplement (424B) for an offering would raise it.
How MS compares with its peers
Over the past month MS ranks 1 of 6 in this group at +5.3%. The best was MS at +5.3% and the weakest was BAC at -1.3%.
MS's P/E of 15.1 is above the peers' median of 13.2. Investors pay more for each dollar of its profit, usually for faster expected growth.
Stock
Close
1 month
3 months
From 52-wk high
P/E
Price/sales
Revenue growth
MS
$190.65
+5.3%
-12.1%
-15.6%
15.1
3.72
+16.2%
JPM
$346.19
+3.2%
-3.6%
-4.7%
14.5
4.53
+13.2%
BAC
$51.02
-1.3%
-19.7%
-20.9%
12.1
2.93
+5.4%
WFC
$86.05
+4.6%
-1.1%
-8.7%
12.1
2.96
+5.4%
C
$124.01
+1.2%
-10.0%
-14.0%
17.7
1.63
+57.3%
GS
$916.56
+2.8%
-12.4%
-20.0%
13.2
3.79
+18.7%
MS history: what happened after similar moves
Since 2023, MS rose 5.3% or more in a month 23 times (separate episodes, not counting the current one). Three months later it was higher in 16 of 22 cases; the median change was +9.3%.
Past moves don't predict the next one; they show how volatile the stock has been.
Month ending
Move in that month
1 month later
3 months later
2026-01-05
+7.4%
-2.9%
-9.2%
2026-04-08
+9.7%
+8.6%
+26.9%
2026-05-07
+8.6%
+11.6%
+14.4%
2026-06-08
+11.6%
+4.7%
+2.4%
2026-07-10
+5.7%
-2.6%
-15.2%
2026-08-27
+6.4%
-9.9%
not yet
The bottom line
MS is up 5.1% over five trading days, closing at $190.65 on Nov. 13, 2026.
Questions people also ask
What is MS's 52-week high and low?
Over the past year MS closed as high as $225.9 and as low as $151.78. At $190.65 on Nov. 13, 2026, it is down 15.6% from the high and 25.6% above the low. More →
Do analysts think MS is a buy?
20 of the 33 analysts who cover Morgan Stanley rate it a buy or strong buy, for a consensus of Buy. Ratings describe analysts' views, not a guarantee. They change after earnings. More →
Are MS insiders buying or selling?
Insiders sold $454,348 of MS on the open market in 90 days and bought none. Sales are often routine, for taxes, diversification or pre-planned plans. Purchases with their own money are the stronger signal.
Who is the largest shareholder of MS?
Among investment managers that file Form 13F, Mitsubishi Ufj Financial Group Inc reported the largest MS position at $78.8 billion. 2728 institutions reported holding MS for Q2 2026.
Is Morgan Stanley profitable?
Yes. Morgan Stanley had $80.2 billion of revenue over the last 12 months. Its net margin was 25.5% and its P/E was 15.1. More →
When does Morgan Stanley report earnings next?
The next report is expected on Jan. 14, 2027, 59 days from now. Morgan Stanley beat the average estimate in all 4 of the last 4 reports.
Dates to watch for MS
Insider trades can come any day: they must be filed on Form 4 within two business days.
Date
Event
Why it matters
Mon Nov 16, 2026
13F filing deadline
Funds disclose what they held on 2026-09-30, including MS.
Fri Nov 20, 2026
Monthly options expiration
Often heavier trading and bigger swings in widely traded stocks.
Wed Dec 9, 2026
Federal Reserve rate decision
Market odds: 4% hold, 1% cut, 96% hike.
Thu Jan 14, 2027
Morgan Stanley earnings
Results and guidance; the biggest scheduled event for the stock.
Key terms on this page
P/E ratio
Price divided by the last 12 months of earnings per share. A P/E of 20 means investors pay $20 for each $1 of yearly profit. It is only defined when the company is profitable.
Form 4
The SEC form a company's officers, directors and 10% owners must file within two business days of buying or selling its stock.
Open-market trade
A purchase or sale on the exchange at the market price, paid with the insider's own money (code P or S on Form 4), as opposed to option exercises, grants or gifts.
Form 13F
A quarterly SEC report listing the U.S. stock holdings of every investment manager with more than $100 million. It is due 45 days after each quarter ends, so it shows positions with a delay.
Dilution
When a company issues new shares, each existing share owns a smaller piece of the company. Common sources: stock offerings, convertible debt and large stock-based pay.
52-week high / low
The highest and lowest daily closing price over the past year (about 252 trading days).
Analyst consensus
The average of Wall Street analysts' ratings (strong buy to strong sell). Analysts skew positive, so a hold is often read as a cautious view.
Where these numbers come from
Every number on this page is computed from the data when the page is refreshed (usually daily); nothing is typed in by hand. This is information, not investment advice.
Price: daily closing prices through Nov. 13, 2026. Changes use 5, 21 and 63 trading days. The 52-week range uses the last 252 closes.
Insider trades: SEC Form 4 filings for the last 90 days, counting only open-market purchases (code P) and sales (code S); option exercises, grants, gifts and filings with data errors are left out.
Analyst ratings: counts of current ratings from 33 analysts, compared with three months ago.
Earnings dates and estimates: a market-data calendar. It shows reported vs expected EPS for the last 4 quarters.
Valuation and growth: revenue, earnings, margins and share counts come from the company's SEC filings. The data is XBRL, for the latest quarter Sep 2026. P/E and price/sales use the latest close.
Fund ownership: SEC Form 13F filings for Q2 2026.
Dilution: share-count changes and offering-related SEC filings over two years, scored 0-100. The filings include shelf registrations, prospectus supplements and convertible notes.
History: 21-trading-day moves over about three years of daily closes, counted once per episode.
Track MS insider trades, dilution and 8-K filings as they're filed.CapitalSnitch puts SEC insider trading, 13F fund ownership and Congress trades inside ChatGPT, Claude, Gemini, Grok and Copilot — ask "Are insiders buying MS?" and get the answer with links to the filings. Free plan, no card; paid plans from $29/month, with instant alerts on Edge.
How this article was made: it was generated from SEC filings and market data with automated tools and is published under Wesley Donovan's editorial responsibility. Spotted an error? Tell us and we will correct it.
Sources: SEC EDGAR (Form 4, 8-K/6-K, prospectuses, XBRL share counts) and daily closing prices. Insider sales are often routine (taxes, diversification, pre-planned 10b5-1 plans). Not investment advice.
Free weekly email:the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.